OLR1 and arteriosclerosis: Proanthocyanidins can prevent the lectin-like oxidized LDL receptor-1 (LOX-1) from recognizing oxidized low-density lipoprotein LDL, which is a factor in the pathophysiology of arteriosclerosis.